Acurx Pharmaceuticals Inc (NASDAQ: ACXP) has experienced a decline in its stock price by -13.64 compared to its previous closing price of 1.32. However, the company has seen a fall of -31.74% in its stock price over the last five trading days. cnbc.com reported 2024-11-20 that The board of Acurx Pharmaceuticals has approved the purchase of up to $1 million in bitcoin to hold as a treasury reserve asset.
Is It Worth Investing in Acurx Pharmaceuticals Inc (NASDAQ: ACXP) Right Now?
The 36-month beta value for ACXP is at -1.82. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ACXP is 14.39M, and currently, shorts hold a 3.30% of that float. The average trading volume for ACXP on November 27, 2024 was 68.61K shares.
ACXP’s Market Performance
ACXP’s stock has seen a -31.74% decrease for the week, with a -39.68% drop in the past month and a -47.95% fall in the past quarter. The volatility ratio for the week is 23.66%, and the volatility levels for the past 30 days are at 9.01% for Acurx Pharmaceuticals Inc The simple moving average for the past 20 days is -32.58% for ACXP’s stock, with a -47.92% simple moving average for the past 200 days.
ACXP Trading at -38.99% from the 50-Day Moving Average
After a stumble in the market that brought ACXP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.41% of loss for the given period.
Volatility was left at 9.01%, however, over the last 30 days, the volatility rate increased by 23.66%, as shares sank -41.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.56% lower at present.
During the last 5 trading sessions, ACXP fell by -31.74%, which changed the moving average for the period of 200-days by -61.87% in comparison to the 20-day moving average, which settled at $1.6910. In addition, Acurx Pharmaceuticals Inc saw -70.23% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ACXP
The total capital return value is set at 0.0. Equity return is now at value -498.16, with -250.15 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
In conclusion, Acurx Pharmaceuticals Inc (ACXP) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
